Terms: = Sarcomas AND ERBB3, c-erbB3, 2065, P21860, p180-ErbB3, c-erbB-3, ErbB-3, MDA-BF-1, HER3, p85-sErbB3, MGC88033, p45-sErbB3, ENSG00000065361, erbB3-S AND Treatment
14 results:
1. A Phase 2 Trial of Afatinib in Patients with Solid Tumors that Harbor Genomic Aberrations in the HER family: The MOBILITY3 Basket Study.
Salawu A; Hansen AR; Spreafico A; Al-Ezzi E; Webster S; Bedard PL; Doi J; Wang L; Siu LL; Abdul Razak AR
Target Oncol; 2022 May; 17(3):271-281. PubMed ID: 35635640
[TBL] [Abstract] [Full Text] [Related]
2. Advanced development of ErbB family-targeted therapies in osteosarcoma treatment.
Wang W; Zhao HF; Yao TF; Gong H
Invest New Drugs; 2019 Feb; 37(1):175-183. PubMed ID: 30353245
[TBL] [Abstract] [Full Text] [Related]
3. Malignant Gliomas as Second Neoplasms in Pediatric Cancer Survivors: Neuropathological Study.
Izycka-Swieszewska E; Bien E; Stefanowicz J; Szurowska E; Szutowicz-Zielinska E; Koczkowska M; Sigorski D; Kloc W; Rogowski W; Adamkiewicz-Drozynska E
Biomed Res Int; 2018; 2018():4596812. PubMed ID: 29805974
[TBL] [Abstract] [Full Text] [Related]
4. Evaluation of patritumab with or without erlotinib in combination with standard cytotoxic agents against pediatric sarcoma xenograft models.
Bandyopadhyay A; Favours E; Phelps DA; Pozo VD; Ghilu S; Kurmashev D; Michalek J; Trevino A; Guttridge D; London C; Hirotani K; Zhang L; Kurmasheva RT; Houghton PJ
Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 29080385
[TBL] [Abstract] [Full Text] [Related]
5. GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS).
Mora J; Castañeda A; Perez-Jaume S; Lopez-Pousa A; Maradiegue E; Valverde C; Martin-Broto J; Garcia Del Muro X; Cruz O; Cruz J; Martinez-Trufero J; Maurel J; Vaz MA; de Alava E; de Torres C
Br J Cancer; 2017 Sep; 117(6):767-774. PubMed ID: 28787430
[TBL] [Abstract] [Full Text] [Related]
6. Genomic landscape of liposarcoma.
Kanojia D; Nagata Y; Garg M; Lee DH; Sato A; Yoshida K; Sato Y; Sanada M; Mayakonda A; Bartenhagen C; Klein HU; Doan NB; Said JW; Mohith S; Gunasekar S; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Myklebost O; Yang H; Dugas M; Meza-Zepeda LA; Silberman AW; Forscher C; Tyner JW; Ogawa S; Koeffler HP
Oncotarget; 2015 Dec; 6(40):42429-44. PubMed ID: 26643872
[TBL] [Abstract] [Full Text] [Related]
7. HSP90 inhibition blocks erbb3 and RET phosphorylation in myxoid/round cell liposarcoma and causes massive cell death in vitro and in vivo.
Safavi S; Järnum S; Vannas C; Udhane S; Jonasson E; Tomic TT; Grundevik P; Fagman H; Hansson M; Kalender Z; Jauhiainen A; Dolatabadi S; Stratford EW; Myklebost O; Eriksson M; Stenman G; Schneider-Stock R; Ståhlberg A; Åman P
Oncotarget; 2016 Jan; 7(1):433-45. PubMed ID: 26595521
[TBL] [Abstract] [Full Text] [Related]
8. Down-regulation of miR-3928 promoted osteosarcoma growth.
Xu H; Liu X; Zhao J
Cell Physiol Biochem; 2014; 33(5):1547-56. PubMed ID: 24854843
[TBL] [Abstract] [Full Text] [Related]
9. erbb3 silencing reduces osteosarcoma cell proliferation and tumor growth in vivo.
Jullien N; Dieudonné FX; Habel N; Marty C; Modrowski D; Patino A; Lecanda F; Sévère N; Marie PJ
Gene; 2013 May; 521(1):55-61. PubMed ID: 23541807
[TBL] [Abstract] [Full Text] [Related]
10. Receptor tyrosine kinase pathway analysis sheds light on similarities between clear-cell sarcoma and metastatic melanoma.
Negri T; Brich S; Conca E; Bozzi F; Orsenigo M; Stacchiotti S; Alberghini M; Mauro V; Gronchi A; Dusio GF; Pelosi G; Picci P; Casali PG; Pierotti MA; Pilotti S
Genes Chromosomes Cancer; 2012 Feb; 51(2):111-26. PubMed ID: 22045652
[TBL] [Abstract] [Full Text] [Related]
11. Activation of the neuregulin-1/ErbB signaling pathway promotes the proliferation of neoplastic Schwann cells in human malignant peripheral nerve sheath tumors.
Stonecypher MS; Byer SJ; Grizzle WE; Carroll SL
Oncogene; 2005 Aug; 24(36):5589-605. PubMed ID: 15897877
[TBL] [Abstract] [Full Text] [Related]
12. Comparison of 17-dimethylaminoethylamino-17-demethoxy-geldanamycin (17DMAG) and 17-allylamino-17-demethoxygeldanamycin (17AAG) in vitro: effects on Hsp90 and client proteins in melanoma models.
Smith V; Sausville EA; Camalier RF; Fiebig HH; Burger AM
Cancer Chemother Pharmacol; 2005 Aug; 56(2):126-37. PubMed ID: 15841378
[TBL] [Abstract] [Full Text] [Related]
13. Classification of clear-cell sarcoma as a subtype of melanoma by genomic profiling.
Segal NH; Pavlidis P; Noble WS; Antonescu CR; Viale A; Wesley UV; Busam K; Gallardo H; DeSantis D; Brennan MF; Cordon-Cardo C; Wolchok JD; Houghton AN
J Clin Oncol; 2003 May; 21(9):1775-81. PubMed ID: 12721254
[TBL] [Abstract] [Full Text] [Related]
14. Expression of HER/erbB family of receptor tyrosine kinases and induction of differentiation by glial growth factor 2 in human rhabdomyosarcoma cells.
Ricci C; Landuzzi L; Rossi I; De Giovanni C; Nicoletti G; Astolfi A; Pupa S; Menard S; Scotlandi K; Nanni P; Lollini PL
Int J Cancer; 2000 Jul; 87(1):29-36. PubMed ID: 10861449
[TBL] [Abstract] [Full Text] [Related]